Literature DB >> 11777138

Feasibility study of colonoscopy as the primary screening investigation in relatives of patients with colorectal cancer.

J M Gilbert1, C J Vaizey, P G Cassell, J Holden.   

Abstract

AIM: Relatives of patients with colorectal cancer are thought to be at a higher risk for this disease than the average population. We aimed to determine whether colonoscopy is a feasible primary screening investigation for this group to identify premalignant and malignant lesions.
METHODS: A total of 449 people underwent colonoscopy and all had one or more relatives with colorectal cancer, of these, 212 were classified as 'asymptomatic' and 237 as being 'symptomatic'. Colonoscopy commenced at 40 years of age or 10 years younger than the youngest affected relative.
RESULTS: Neoplastic change, benign and malignant, was found in 25.5% of the 'asymptomatic' group and 24% of the 'symptomatic' group; in 26% of those with one first degree relative, 39% with two or more first degree relatives and only 19% with second degree relatives. 38% of lesions were out of reach of a flexible sigmoidoscope. No known complications occurred.
CONCLUSIONS: It is feasible to perform colonoscopy as the primary investigation for the first degree relatives of patients with colorectal cancer. The yield of neoplastic lesions is sufficient to make this appropriate.

Entities:  

Mesh:

Year:  2001        PMID: 11777138      PMCID: PMC2503678     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  21 in total

1.  Implementing screening for colorectal cancer.

Authors:  W Atkin
Journal:  BMJ       Date:  1999-11-06

2.  Frequency of hereditary colorectal carcinoma.

Authors:  J P Mecklin
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

Review 3.  Screening for colorectal cancer.

Authors:  D F Ransohoff; C A Lang
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

Review 4.  Colorectal cancer: risk factors and recommendations for early detection.

Authors:  T E Read; I J Kodner
Journal:  Am Fam Physician       Date:  1999-06       Impact factor: 3.292

Review 5.  Colorectal cancer: the case for endoscopic screening.

Authors:  P G Reasbeck
Journal:  Br J Surg       Date:  1987-01       Impact factor: 6.939

6.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.

Authors:  R S Houlston; V Murday; C Harocopos; C B Williams; J Slack
Journal:  BMJ       Date:  1990 Aug 18-25

7.  Single-visit screening and treatment of first-degree relatives. Colon cancer pilot study.

Authors:  G W Stevenson; C Hernandez
Journal:  Dis Colon Rectum       Date:  1991-12       Impact factor: 4.585

Review 8.  Primary therapy of carcinoma of the large bowel.

Authors:  V W Fazio; J J Tjandra
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

Review 9.  Do all colorectal carcinomas arise in preexisting adenomas?

Authors:  J R Jass
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

Review 10.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

View more
  3 in total

1.  Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment.

Authors:  Kirsten Howard; Glenn Salkeld; Michael Pignone; Peter Hewett; Peter Cheung; Julie Olsen; Wayne Clapton; Ian C Roberts-Thomson
Journal:  Value Health       Date:  2011-12       Impact factor: 5.725

2.  Symptomatic presentation of early colorectal cancer.

Authors:  D Smith; M Ballal; R Hodder; G Soin; S N Selvachandran; D Cade
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

3.  22-year longitudinal study of repetitive colonoscopy in patients with a family history of colorectal cancer.

Authors:  J K Randall; C S Good; J M Gilbert
Journal:  Ann R Coll Surg Engl       Date:  2013-11       Impact factor: 1.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.